Results 121 to 130 of about 23,130 (165)

Biopharmaceutical benchmarks 2006

Nature Biotechnology, 2006
The rate of biopharmaceutical approvals has leveled off, but some milestones bode well for the future.
openaire   +2 more sources

Growing pains for biopharmaceuticals

Nature Biotechnology, 2001
Biopharmaceuticals have provided a swift means of swelling pharmaceutical company pipelines, but they may not be such a fast “fix” for the industry in the future.
openaire   +2 more sources

Microneedle-Mediated Transdermal Delivery of Biopharmaceuticals

Pharmaceutics, 2023
Chien Nguyen, Hiep Nguyen
exaly  

Biopharmaceuticals

2023
Serena Dasani, Rohan Palanki, Pallavi Menon, Sourav K. Bose   +3 more
openaire   +1 more source

Immunotoxicology of Biopharmaceutics

2010
H.G. Haggerty, K.D. Price, J.M. Shenton
openaire   +1 more source

Emerging trends in pulmonary delivery of biopharmaceuticals

Drug Discovery Today, 2022
Sarika Wairkar
exaly  

Definition, categorization, and environmental risk assessment of biopharmaceuticals

Science of the Total Environment, 2021
Steffen Foss Hansen
exaly  

Biopharmaceutical benchmarks

Nature Biotechnology, 2000
openaire   +2 more sources

Innovative Drying Technologies for Biopharmaceuticals

International Journal of Pharmaceutics, 2021
Ashutosh Sharma, Helen Hughes, Dikshitkumar Khamar   +2 more
exaly  

Approaches for the detection and analysis of antidrug antibodies to biopharmaceuticals: A review

Journal of Separation Science, 2022
David Hage, Kyungah Suh
exaly